Skip to main content
. 2020 Oct 25;35(2):e23633. doi: 10.1002/jcla.23633

Figure 2.

Figure 2

Three‐year survival of patients in the two groups. The 3‐year survival rate in the OG (61.76%) was significantly higher than that in the CG (40.74%) (P < .05)